An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma
Titel:
An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma
Auteur:
Vij, Ravi Wang, Michael Kaufman, Jonathan L. Lonial, Sagar Jakubowiak, Andrzej J. Stewart, A. Keith Kukreti, Vishal Jagannath, Sundar McDonagh, Kevin T. Alsina, Melissa Bahlis, Nizar J. Reu, Frederic J. Gabrail, Nashat Y. Belch, Andrew Matous, Jeffrey V. Lee, Peter Rosen, Peter Sebag, Michael Vesole, David H. Kunkel, Lori A. Wear, Sandra M. Wong, Alvin F. Orlowski, Robert Z. Siegel, David S.